Mitsudomi T - Search Results

1

Toyooka S, Mitsudomi T, Soh J, Aokage K, Yamane M, Oto T, Kiura K, Miyoshi S. Toyooka S, et al. Among authors: mitsudomi t. Gen Thorac Cardiovasc Surg. 2011 Aug;59(8):527-37. doi: 10.1007/s11748-010-0743-3. Epub 2011 Aug 18. Gen Thorac Cardiovasc Surg. 2011. PMID: 21850578 Review.

2

Molecular lesions as targets for diagnosis and therapy of lung cancer.

Mitsudomi T. Mitsudomi T. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:112-6. Gan To Kagaku Ryoho. 2002. PMID: 11890096

3

A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical intervention.

Ichinose Y, Tsuchiya R, Koike T, Yasumitsu T, Nakamura K, Tada H, Yoshimura H, Mitsudomi T, Nakagawa K, Yokoi K, Kato H. Ichinose Y, et al. Among authors: mitsudomi t. J Thorac Cardiovasc Surg. 2002 Apr;123(4):695-9. doi: 10.1067/mtc.2002.120712. J Thorac Cardiovasc Surg. 2002. PMID: 11986597 Free article. Clinical Trial.

4

[Molecular abnormalities in lung cancer].

Shimizu S, Mitsudomi T. Shimizu S, et al. Among authors: mitsudomi t. Nihon Rinsho. 2002 May;60 Suppl 5:73-7. Nihon Rinsho. 2002. PMID: 12101773 Review. Japanese. No abstract available.

5

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: mitsudomi t. Int J Cancer. 2003 Aug 10;106(1):45-51. doi: 10.1002/ijc.11184. Int J Cancer. 2003. PMID: 12794755 Free article.

6

Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients.

Tomida S, Koshikawa K, Yatabe Y, Harano T, Ogura N, Mitsudomi T, Some M, Yanagisawa K, Takahashi T, Osada H, Takahashi T. Tomida S, et al. Among authors: mitsudomi t. Oncogene. 2004 Jul 8;23(31):5360-70. doi: 10.1038/sj.onc.1207697. Oncogene. 2004. PMID: 15064725

7

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Kosaka T, et al. Among authors: mitsudomi t. Cancer Res. 2004 Dec 15;64(24):8919-23. doi: 10.1158/0008-5472.CAN-04-2818. Cancer Res. 2004. PMID: 15604253

8

Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S, Mitsudomi T, Takahashi T. Karube Y, et al. Among authors: mitsudomi t. Cancer Sci. 2005 Feb;96(2):111-5. doi: 10.1111/j.1349-7006.2005.00015.x. Cancer Sci. 2005. PMID: 15723655 Free article.

9

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.

Mitsudomi T, Kosaka T, Endoh H, Horio Y, Hida T, Mori S, Hatooka S, Shinoda M, Takahashi T, Yatabe Y. Mitsudomi T, et al. J Clin Oncol. 2005 Apr 10;23(11):2513-20. doi: 10.1200/JCO.2005.00.992. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738541 Clinical Trial.

10

EGFR mutation and response of lung cancer to gefitinib.

Toyooka S, Kiura K, Mitsudomi T. Toyooka S, et al. Among authors: mitsudomi t. N Engl J Med. 2005 May 19;352(20):2136; author reply 2136. doi: 10.1056/NEJM200505193522019. N Engl J Med. 2005. PMID: 15901872 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

483 results

Search Page